Search Options Stock News and Analysis from Schaeffer's

https://www.schaeffersresearch.com/content/options/2023/08/07/2-biotech-stocks-staging-large-swings

8/7/2023 2:32 PM

Sage Therapeutics Inc (NASDAQ:SAGE) is crumbling to record lows today, down 52.2% at $17.25 at last check, earlier hitting a low of $16.69. The U.S. Food & Drug Administration (FDA) approved its drug...

Biotech Stock Moves Higher After Fast-Track Designation

https://www.schaeffersresearch.com/content/news/2021/09/15/biotech-stock-moves-higher-after-fast-track-designation

9/15/2021 1:36 PM

SAGE Therapeutics Inc (NYSE:SAGE) is in the spotlight today, after the drugmaker received fast-track designation from the U.S. Food and Drug Administration (FDA) for its potential Huntington's diseas...

SAGE Plummets After Drug Trial Results

https://www.schaeffersresearch.com/content/news/2021/06/15/sage-plummets-after-drug-trial-results

6/15/2021 11:07 AM

The shares of Sage Therapeutics Inc (NASDAQ:SAGE) are down 16.5% to trade at $60.85 at last check, following lackluster Phase 3 test results for the biotechnology company's depression drug, Zuranolon...

Sage Stock Slips Amid Biogen Deal Critique

https://www.schaeffersresearch.com/content/news/2020/12/01/sage-stock-slips-amid-biogen-deal-critique

12/1/2020 11:57 AM

The shares of Sage Therapeutics Inc (NASDAQ:SAGE) are down 1.8% at $72.78 at last check, after Raymond James downgraded the stock to "Market Perform" from "Outperform," following its recent $1.5 bill...

The Options Strategy Perfect for Volatile Markets

https://www.schaeffersresearch.com/content/options/2020/03/27/the-options-strategy-perfect-for-volatile-markets

3/27/2020 12:45 PM

A long volatility/ straddle strategy might be a good idea for the current roller-coaster market environment we're experiencing. Having a set allocation of your portfolio with these types of trades can...

PEOPLE ALSO SEARCH FOR

-intraday-options-activity